Anesiva, Inc. announced today that it will present additional Phase 2 data on 4975 for the treatment of post-surgical pain associated with total knee replacement surgeries.
From: biz.yahoo.com
Anesiva to Present Additional Phase 2 Data at American Pain Society Meeting on 4975 for Treatment of Post-Surgical Pain ...
Posted by Ruslan Abuzant at 6:49 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment